Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof.
Davis RR, Li B, Yun SY, Chan A, Nareddy P, Gunawan S, Ayaz M, Lawrence HR, Reuther GW, Lawrence NJ, Schönbrunn E.
Davis RR, et al. Among authors: chan a.
J Med Chem. 2021 Feb 25;64(4):2228-2241. doi: 10.1021/acs.jmedchem.0c01952. Epub 2021 Feb 11.
J Med Chem. 2021.
PMID: 33570945
Free PMC article.